Announcements Trials
Browse Landscape

Phase

Phase NA 34Phase 2 5Phase 3 4Phase 4 2Phase 1/2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 255Breast Neoplasms 171Neoplasms 166Colorectal Neoplasms 152Neoplasm Metastasis 125Prostatic Neoplasms 118Recurrence 117Leukemia, Myeloid, Acute 117Melanoma 116Pancreatic Neoplasms 114Ovarian Neoplasms 109Multiple Myeloma 105Lung Neoplasms 94Stomach Neoplasms 92Triple Negative Breast Neoplasms 86Squamous Cell Carcinoma of Head and Neck 86Lymphoma 77Glioblastoma 77Lymphoma, Non-Hodgkin 76Lymphoma, Large B-Cell, Diffuse 65Carcinoma, Renal Cell 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 63Carcinoma, Hepatocellular 58Endometrial Neoplasms 56Advanced Solid Tumor 56Small Cell Lung Carcinoma 55Uterine Cervical Neoplasms 53Sarcoma 53Myelodysplastic Syndromes 51Leukemia 50

Interventions

Modafinil 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Cognitive Dysfunction × 1 year × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

NCT05333250 2026-01-13

MODIFY

Ottawa Hospital Research Institute

Phase 1/2 Recruiting
40 enrolled

Fatigue, Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡